BREAKING NEWS: Prof Todd Davenport & CPTJ Dedicated to Long COVID Rehabilitation
Breaking News Prof Todd Davenport Edits the January edition of CPTJ Dedicated to Long COVID Rehabilitation
Breaking News Prof Todd Davenport Edits the January edition of CPTJ Dedicated to Long COVID Rehabilitation
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E27: Dr. David Putrino discusses the hormonal and neurological impacts of Long COVID, highlighting key research findings, symptom patterns, and emerging treatments through
E26: Explore cutting-edge research on Long COVID and ME/CFS with Dr. Nancy Klimas, uncovering innovative treatments, immune system insights, and the transformative potential
E25: Explore Mast Cell Activation Syndrome (MCAS) with Dr. Funmi Okunola and Dr. David L. Kaufman. Uncover diagnostic challenges, innovative treatments, and expert
E23 In this episode, the Post COVID Long-term Recovery Collaborative (PLRC) members Lisa McCorkell, Gina Assaf, and Letícia Soares discuss their work supporting
PROFESSOR KLIMAS HAS FDA APPROVAL FOR MONOCLONAL ANTIBODY RESEARCH!
E23 Join Prof Nancy Klimas to discover groundbreaking insights into Long COVID treatments! Explore how monoclonal antibodies offer hope by targeting viral persistence
E22: Discover how patient-led research is transforming ME/CFS and long COVID advocacy. Join us to explore groundbreaking studies, inclusive efforts, and the fight